FOLH1 and posterior cortical atrophy: Based on evidence regarding safety and efficacy, two PSMA-targeted pseudopeptides were recently approved by the FDA for PCa imaging (Figure 6): [68Ga]Ga-PSMA-11 [59] and [18F]DCFPyL [60].